Last edition
News about "Travoprost Ophthalmic Solution "
Alembic Pharma Wins USFDA Approval for Travoprost Ophthalmic Solution
Alembic Pharmaceuticals has secured USFDA approval for its Travoprost Ophthalmic Solution, with the ANDA deemed therapeutically equivalent to the reference listed drug Travatan Z (0.004%) from Sandoz.
Travoprost Ophthalmic Solution | 18/12/2025 | By News Bureau
Sagent Pharmaceuticals Enters Ophthalmic Market, Launches Travoprost Ophthalmic Solution
Travoprost is the first ophthalmic product offering in Sagent's portfolio, with plans to launch more products in the coming year.
Travoprost Ophthalmic Solution | 16/09/2025 | By Dineshwori | 124
Glenmark Rolls Out Travoprost Ophthalmic Solution
Glenmark’s Travoprost Ophthalmic Solution USP, 0.004 percent is bioequivalent and therapeutically equivalent to the reference listed drug, Travatan Z Ophthalmic Solution USP, 0.004 percent of Sandoz, Inc.
Travoprost Ophthalmic Solution | 27/11/2024 | By Aishwarya | 218
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy